Navigation Links
Elsevier announces the launch of open access journal: Pathogenesis
Date:1/29/2014

Oxford, January 29, 2014 -- Elsevier, world-leading provider of scientific, technical and medical information products and services, announces the launch of open access journal, Pathogenesis.

Pathogenesis will be published on behalf of The Royal College of Pathologists a professional membership organization committed to setting and maintaining professional standards and promoting excellence in the practice of Pathology. The College represents 19 pathology specialties and has over 10,000 members working in hospital laboratories, universities and industry, worldwide.

Pathogenesis will provide a home for research covering all areas of illness and normal cellular and molecular development in human and veterinary disease. The journal Pathogenesis will publish peer reviewed original scientific research articles and high quality reviews, editorials and letters to the editor which report on multidisciplinary areas of Molecular and Diagnostic Pathology, Cellular Mechanisms as well as aspects of Haematology, Proteomics, Virology, Microbiology and Chemical Pathology.

The Editor-in-Chief of the journal, Professor Finbarr Cotter, Barts Cancer Institute, Queen Mary University of London, UK said of the launch, "This is a tremendous cooperation between The Royal College of Pathologists and Elsevier, one which confirms the major commitment by the College towards the modernization of the field of pathology with both academic and molecular pathology leading the way."

Professor Cotter will work closely with Section Editors: Professor Ian Cree University Hospital Coventry and Warwickshire, UK and Dr George Vassilou, Wellcome Trust Sanger Institute, Cambridge, UK.

"We are delighted to announce the launch of this new open access journal. We look forward to working together with the journal editors and The Royal College of Pathologists offering their members, researchers and clinicians a platform through which they can publish their research quickly and make it widely available," said Rachel Garland, Publisher at Elsevier.


'/>"/>

Contact: Mareille Prevo
m.prevo@elsevier.com
31-204-853-783
Elsevier
Source:Eurekalert

Related biology news :

1. Elsevier launches new journal Algal Research
2. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
3. Reed Elsevier Environmental Challenge shortlists 2012 projects
4. Elsevier launches new journal: International Journal of Disaster Risk Reduction
5. Elsevier launches International Journal for Parasitology: Parasites and Wildlife
6. Elsevier launches new open access journal: Applied and Translational Genomics
7. 2012 Reed Elsevier Environmental Challenge winners announced
8. Elsevier launches new open access journal -- Case Studies in Engineering Failure Analysis
9. Elsevier launches new journal: Journal of Unconventional Oil and Gas Resources
10. Elsevier launches new open access journal: Molecular Metabolism
11. Elsevier announces the launch of a new journal: Anthropocene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2020)... ... May 06, 2020 , ... Sickle Cell Disease ... medical technology company dedicated to improving the quality, safety, efficacy and cost of red ... help SCDAA deliver on its mission and meet its goals. In 2020 Hemanext will ...
(Date:5/1/2020)... ... 30, 2020 , ... Flagship Biosciences , providers of ... biopharmaceutical and regulatory services advisor. The companies now deliver regulatory strategy and support ... taking a collaborative approach to empower more confident and informed regulatory decisions through ...
(Date:4/30/2020)... LOS ALAMOS, N.M. (PRWEB) , ... April 28, 2020 , ... ... some of the world’s biggest challenges in agriculture and aquaculture with the mission of ... eight presenters at the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ...
Breaking Biology News(10 mins):
(Date:5/28/2020)... Switzerland (PRWEB) , ... May 28, 2020 , ... ... biopharmaceutical R&D, today announced the release of Genedata Screener ® 17.0, the ... of screening data from all in-vitro screening assay technologies. Genedata will host a ...
(Date:5/21/2020)... ... , ... Threats to intellectual property, political pressure to lower ... wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new ... commercially weaker, dealing with delays in new product launches and with fewer resources ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... Prakash, who will serve as the company’s executive vice president of product engineering ... Exo is disrupting the medical imaging space, bringing more than 24 years of ...
(Date:5/15/2020)... ... , ... This new service offers clients a way to speak with Subject ... the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of ... OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am – ...
Breaking Biology Technology: